Truqap is a kinase inhibitor that actually works by blocking pathways that assistance the cancer cells endure and expand, so lowers cancer development. Truqap is from a class of medicines called an AKT inhibitor. Truqap received FDA acceptance on November 17, 2023, after positive success from your C